 "Need cash now? Avoid taking a personal loan for discretionary purchases")
Private equity player The Carlyle Group has signed up to acquire a majority 74 per cent stake in Mumbai-headquartered animal health care company SeQuent Scientific for over Rs 1,500 crore.
The transaction is being done through an equity purchase stake that values each share at Rs 86. The deal will be executed through two investment vehicles — CA Harbor Investments, affiliated entity of CAP V Mauritius, which is an affiliated entity of Carlyle. The deal is first control investment in an Indian publicly-listed company for Carlyle.
Carlyle's global portfolio in the animal nutrition and health care sectors include Manna Pro
